Here At Last: EU Guidance On Quality Rules For Drug-Device Combinations
Executive Summary
You may also be interested in...
Regulators Urged To Avoid ‘Conflicting’ Clinical Requirements For Drug-Device Combinations In EU
EU regulators are being urged to get their skates on and publish guidance on new clinical requirements that will kick in soon for integral drug-device combination products.
No Shocks Expected In EU Quality Guidance For Drug-Device Combinations
Long-awaited draft EU guidance on the quality requirements for integral and non-integral drug-device combination products will be published very soon.
EMA Issues Guidance On Medical Devices That Are Integral To Pharma Products
The Medical Devices Regulation (MDR) is the vehicle to clarify the role of EU notified bodies in medicinal products with integral medical devices, such as pre-filled syringes. Now, guidance from the EMA on the MDR shows how the pharma and device sectors are working increasingly collaboratively.